Exhibit 3. MHRA (2007) in the context of extemporaneous preparation [14].

Extemporaneously prepared medicines should be formulated and prepared in compliance with current legal requirements and standards. Preparation and quality control arrangements are to be documented and in compliance with current GPP requirements. All products prepared should be quality suitable for their intended use Products are released for patient use only by a pharmacist. Documentation and records should comply recommendations in this guidance document.